Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Paediatric Drugs|December 9, 2003
Efficacy and safety of Ritalin LA, a new, once daily, extended-release dosage form of methylphenidate, in children with attention deficit hyperactivity disorderJoseph Biederman, Declan Quinn, Margaret Weiss, et al.
The Lancet. Neurology|November 18, 2006
TCH346 as a neuroprotective drug in Parkinson's disease: a double-blind, randomised, controlled trialC Warren Olanow, Anthony H V Schapira, Peter A LeWitt, et al.
Neurology|December 17, 2020
Siponimod and Cognition in Secondary Progressive Multiple Sclerosis: EXPAND Secondary AnalysesRalph H B Benedict, Davorka Tomic, Bruce A Cree, et al.
The Lancet. Neurology|June 15, 2013
Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 studyKrzysztof Selmaj, David K B Li, Hans-Peter Hartung, et al.
Pageof 1